ATRO Stock Analysis: Astronics | NASDAQ
Aerospace & Defense | NASDAQ, USA | Market Cap: 2.578m USD | 12M Return: 45.8% | US0464331083 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 30.1M
Qual. Beats: 1
Rev. Trend: -46.8%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Astronics Corporation (ATRO) is a U.S.-based aerospace and defense supplier that designs and manufactures specialized products through two operating segments: Aerospace and Test Systems. The Aerospace segment provides lighting, safety systems, electrical power generation and distribution, seat motion systems, aircraft structures, and avionics products, serving airframe OEMs, airlines, and branches of the U.S. Department of Defense. The Test Systems segment produces automated test equipment and training/simulation devices for aerospace, defense, communications, and mass transit customers, including government prime contractors.
The company sells into multiple end markets-commercial transport, military, and general aviation-which provides diversification across both commercial and defense cycles. As a Tier 1 supplier to major airframe manufacturers, Astronics operates in the highly regulated aerospace supply chain, where long product qualification cycles and aftermarket service revenue are typical features of the business model.
- Boeing 737 production ramp drives Aerospace segment revenue recovery
- Defense budget growth boosts avionics and military lighting demand
- Test Systems margin expansion supports path to profitability
| Net Income: 79.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.50 > 1.0 |
| NWC/Revenue: 34.22% < 20% (prev 34.13%; Δ 0.09% < -1%) |
| CFO/TA 0.14 > 3% & CFO 103.3m > Net Income 79.1m |
| Net Debt (386.6m) to EBITDA (116.6m): 3.31 < 3 |
| Current Ratio: 2.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.5m) vs 12m ago 27.96% < -2% |
| Gross Margin: 32.54% > 18% (prev 25.09%; Δ 7.44% > 0.5%) |
| Asset Turnover: 133.9% > 50% (prev 127.2%; Δ 6.62% > 0%) |
| Interest Coverage Ratio: 8.52 > 6 (EBIT TTM 93.5m / Interest Expense TTM 11.0m) |
| A: 0.42 (Total Current Assets 485.7m - Total Current Liabilities 163.4m) / Total Assets 760.8m |
| B: 0.28 (Retained Earnings 216.7m / Total Assets 760.8m) |
| C: 0.13 (EBIT TTM 93.5m / Avg Total Assets 703.8m) |
| D: 0.35 (Book Value of Equity 198.2m / Total Liabilities 562.6m) |
| Altman-Z'' = 4.97 = AAA |
| DSRI: 1.07 (Receivables 228.9m/187.3m, Revenue 942.1m/822.9m) |
| GMI: 0.77 (GM 25.09% / 32.54%) |
| AQI: 0.97 (AQ_t 0.17 / AQ_t-1 0.17) |
| SGI: 1.14 (Revenue 942.1m / 822.9m) |
| TATA: -0.03 (NI 79.1m - CFO 103.3m) / TA 760.8m) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of November 09, 2026, the stock is trading at USD 54.71 with a total of 338,969 shares traded. Over the past week, the price has changed by -7.88%, over one month by -20.89%, over three months by -28.05% and over the past year by +45.82%.
Current recommended Stop Loss: 50.80 (which is 7.1% or 1.2 ATR below the current price).
Astronics has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy ATRO.
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 98 | 79.1% |
P/E Trailing = 32.7596
P/E Forward = 27.1739
P/S = 2.7369
P/B = 12.8862
P/EG = 1.4507
Revenue TTM = 942.1m USD
EBIT TTM = 93.5m USD
EBITDA TTM = 116.6m USD
Long Term Debt = 310.3m USD (from longTermDebt, last quarter)
Short Term Debt = 5.93m USD (from shortTermDebt, last quarter)
Debt = 395.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 42.6m
Net Debt = 386.6m USD (calculated: Debt 395.6m - CCE 9.02m)
Enterprise Value = 2.96b USD (2.58b + Debt 395.6m - CCE 9.02m)
Interest Coverage Ratio = 8.52 (Ebit TTM 93.5m / Interest Expense TTM 11.0m)
EV/FCF = 48.27x (Enterprise Value 2.96b / FCF TTM 61.4m)
FCF Yield = 2.07% (FCF TTM 61.4m / Enterprise Value 2.96b)
FCF Margin = 6.52% (FCF TTM 61.4m / Revenue TTM 942.1m)
Net Margin = 8.40% (Net Income TTM 79.1m / Revenue TTM 942.1m)
Gross Margin = 32.54% ((Revenue TTM 942.1m - Cost of Revenue TTM 635.6m) / Revenue TTM)
Gross Margin QoQ = 33.43% (prev 32.58%)
Tobins Q-Ratio = 3.90 (Enterprise Value 2.96b / Total Assets 760.8m)
Interest Expense / Debt = 2.78% (Interest Expense 11.0m / Debt 395.6m)
Taxrate = 4.17% (3.44m / 82.6m)
NOPAT = 89.6m (EBIT 93.5m * (1 - 4.17%))
Current Ratio = 2.97 (Total Current Assets 485.7m / Total Current Liabilities 163.4m)
Debt / Equity = 2.00 (Debt 395.6m / totalStockholderEquity, last quarter 198.2m)
Debt / EBITDA = 3.31 (Net Debt 386.6m / EBITDA 116.6m)
Debt / FCF = 6.29 (Net Debt 386.6m / FCF TTM 61.4m)
Total Stockholder Equity = 152.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.24% (Net Income 79.1m / Total Assets 760.8m)
RoE = 51.97% (Net Income TTM 79.1m / Total Stockholder Equity 152.2m)
RoCE = 20.22% (EBIT 93.5m / Capital Employed (Equity 152.2m + L.T.Debt 310.3m))
RoIC = 15.08% (NOPAT 89.6m / Invested Capital 594.4m)
WACC = 9.09% (E(2.58b)/V(2.97b) * Re(10.08%) + D(395.6m)/V(2.97b) * Rd(2.78%) * (1-Tc(0.04)))
Discount Rate = 10.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.10 | Cagr: 13.69%
[DCF] Terminal Value 75.60% ; FCFF base≈51.3m ; Y1≈58.8m ; Y5≈86.5m
[DCF] Fair Price = 21.18 (EV 1.15b - Net Debt 386.6m = Equity 764.6m / Shares 36.1m; r=9.09% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.30 | # QB: 1
Revenue Correlation: -46.82 | Revenue CAGR: -5.71% | SUE: 2.46 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.72 | Chg30d=+0.35% | Revisions=-25% | Analysts=5
EPS current Year (2026-12-31): EPS=2.71 | Chg30d=-0.37% | Revisions=-25% | GrowthEPS=+61.8% | GrowthRev=+19.8%
EPS next Year (2027-12-31): EPS=3.06 | Chg30d=-2.62% | Revisions=+50% | GrowthEPS=+13.1% | GrowthRev=+9.7%
[Analyst] Revisions Ratio: +12% (up=3, down=2)